These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8275063)

  • 1. Prognostic value of pretreatment social adaptation in bulimia nervosa.
    Steiger H; Leung F; Thibaudeau J
    Int J Eat Disord; 1993 Nov; 14(3):269-76. PubMed ID: 8275063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of cognitive-behavioral and supportive-expressive therapy for bulimia nervosa.
    Garner DM; Rockert W; Davis R; Garner MV; Olmsted MP; Eagle M
    Am J Psychiatry; 1993 Jan; 150(1):37-46. PubMed ID: 8417578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic indicators in bulimia nervosa treated with cognitive-behavioral group therapy.
    Blouin JH; Carter J; Blouin AG; Tener L; Schnare-Hayes K; Zuro C; Barlow J; Perez E
    Int J Eat Disord; 1994 Mar; 15(2):113-23. PubMed ID: 8173557
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comorbid features in bulimics before and after therapy: are they explained by axis II diagnoses, secondary effects of bulimia, or both?
    Steiger H; Leung F; Thibaudeau J; Houle L; Ghadirian AM
    Compr Psychiatry; 1993; 34(1):45-53. PubMed ID: 8425392
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Why the high rate of dropout from individualized cognitive-behavior therapy for bulimia nervosa?
    Steel Z; Jones J; Adcock S; Clancy R; Bridgford-West L; Austin J
    Int J Eat Disord; 2000 Sep; 28(2):209-14. PubMed ID: 10897083
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic utility of subcomponents of the borderline personality construct in bulimia nervosa.
    Steiger H; Leung F; Thibaudeau J; Houle L
    Br J Clin Psychol; 1993 May; 32(2):187-97. PubMed ID: 8318936
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An open trial of light therapy for women with seasonal affective disorder and comorbid bulimia nervosa.
    Lam RW; Lee SK; Tam EM; Grewal A; Yatham LN
    J Clin Psychiatry; 2001 Mar; 62(3):164-8. PubMed ID: 11305701
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postremission predictors of relapse in women with eating disorders.
    Keel PK; Dorer DJ; Franko DL; Jackson SC; Herzog DB
    Am J Psychiatry; 2005 Dec; 162(12):2263-8. PubMed ID: 16330589
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A controlled study of light therapy for bulimia nervosa.
    Lam RW; Goldner EM; Solyom L; Remick RA
    Am J Psychiatry; 1994 May; 151(5):744-50. PubMed ID: 8166318
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Four-year follow-up of guided self-change for bulimia nervosa.
    Thiels C; Schmidt U; Treasure J; Garthe R
    Eat Weight Disord; 2003 Sep; 8(3):212-7. PubMed ID: 14649785
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication and psychotherapy in the treatment of bulimia nervosa.
    Walsh BT; Wilson GT; Loeb KL; Devlin MJ; Pike KM; Roose SP; Fleiss J; Waternaux C
    Am J Psychiatry; 1997 Apr; 154(4):523-31. PubMed ID: 9090340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Commitment to treatment goals in prediction of group cognitive-behavioral therapy treatment outcome for women with bulimia nervosa.
    Mussell MP; Mitchell JE; Crosby RD; Fulkerson JA; Hoberman HM; Romano JL
    J Consult Clin Psychol; 2000 Jun; 68(3):432-7. PubMed ID: 10883560
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impulsivity and dyscontrol in bulimia nervosa: is impulsivity an independent phenomenon or a marker of severity?
    Newton JR; Freeman CP; Munro J
    Acta Psychiatr Scand; 1993 Jun; 87(6):389-94. PubMed ID: 8356889
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Predictors of 1-year treatment outcome in bulimia nervosa.
    Bulik CM; Sullivan PF; Joyce PR; Carter FA; McIntosh VV
    Compr Psychiatry; 1998; 39(4):206-14. PubMed ID: 9675505
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A multicenter comparison of cognitive-behavioral therapy and interpersonal psychotherapy for bulimia nervosa.
    Agras WS; Walsh T; Fairburn CG; Wilson GT; Kraemer HC
    Arch Gen Psychiatry; 2000 May; 57(5):459-66. PubMed ID: 10807486
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cognitive-behavioral group psychotherapy of bulimia nervosa: importance of logistical variables.
    Mitchell JE; Pyle RL; Pomeroy C; Zollman M; Crosby R; Seim H; Eckert ED; Zimmerman R
    Int J Eat Disord; 1993 Nov; 14(3):277-87. PubMed ID: 8275064
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting dropout rate from cognitive-behavioral group treatment for bulimia nervosa.
    Blouin J; Schnarre K; Carter J; Blouin A; Tener L; Zuro C; Barlow J
    Int J Eat Disord; 1995 May; 17(4):323-9. PubMed ID: 7620471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thyroid indices and treatment outcome in bulimia nervosa.
    Gendall KA; Joyce PR; Carter FA; McIntosh VV; Bulik CM
    Acta Psychiatr Scand; 2003 Sep; 108(3):190-5. PubMed ID: 12890273
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictors of short-term treatment outcome in bulimia nervosa inpatients.
    Bossert S; Schmölz U; Wiegand M; Junker M; Krieg JC
    Behav Res Ther; 1992 Mar; 30(2):193-9. PubMed ID: 1567348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three psychological treatments for bulimia nervosa. A comparative trial.
    Fairburn CG; Jones R; Peveler RC; Carr SJ; Solomon RA; O'Connor ME; Burton J; Hope RA
    Arch Gen Psychiatry; 1991 May; 48(5):463-9. PubMed ID: 2021299
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.